NDR for Institutional Investors (Introducing Subsidiary Verismo Therapeutics)
-
IR event: NDR for domestic and foreign institutional investors in Seoul, May 6-8, 2026
-
Purpose: Enhance investor understanding and corporate value
-
Main content: Business explanation and Q&A on subsidiary Verismo Therapeutics
KOSDAQ Filing Information
-
-
Holding of Investor Relations Conference (IR)
-
Company: HLB innoVation (024850)
-
Submission: HLB innoVation Co.,Ltd.
-
Under KRX KOSDAQ Market Division
-
-
Shares: 157,382,650
-
Price: 4,620 KRW
-
Market Cap: 727.1 B KRW